Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azithromycin for chronic rejection after lung transplantation
2006-000485-36Phase 4Completed
- Sponsor
- Newcastle Hospitals NHS Foundation Trust
- Start
- Sep 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Bronchiolitis Obliterans Syndrome (BOS) and chronic lung allograft dysfunction (CLAD) comparing Azithromycin with Placebo (2 arms). Primary endpoint: Change in FEV1 over 3 months. Started Sep 2006; status: completed.
02
Drugs
azithromycin
03
Conditions
Bronchiolitis Obliterans Syndrome (BOS)chronic lung allograft dysfunction (CLAD)
Beyond the preview
Go deeper on 2006-000485-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-000485-36.